Royal Bank of Canada set a $20.00 price objective on Bausch + Lomb (NYSE:BLCO – Free Report) in a research note issued to investors on Friday morning, BayStreet.CA reports. The brokerage currently has an outperform rating on the stock. BLCO has been the topic of a number of other reports. HC Wainwright dropped their price […]
Coronation Fund Managers Ltd. Buys 29,662 Shares of Bausch + Lomb Co. (NYSE:BLCO) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Bausch + Lomb (NYSE:BLCO – Get Free Report) and Strategic Global Investments (OTCMKTS:STBV – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends. Volatility and Risk Bausch + Lomb […]
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis torontotelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from torontotelegraph.com Daily Mail and Mail on Sunday newspapers.
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.